Abstract
Background SARS-CoV-2 and influenza are lipid-enveloped viruses with differential morbidity and mortality but shared modes of transmission.
Objective With a descriptive epidemiological framing, we assessed whether recent historical patterns of regional influenza burden are reflected in the observed heterogeneity in COVID-19 cases across regions of the world.
Methods Weekly surveillance data reported by the World Health Organization from January 2017– December 2019 for influenza and through October 31, 2020 for COVID-19 were used to assess seasonal and temporal trends for influenza and COVID-19 cases across the seven World Bank regions.
Results In regions with more pronounced influenza seasonality, COVID-19 epidemics have largely followed trends similar to those seen for influenza from 2017-2019. COVID-19 epidemics in countries across Europe and Central Asia and North America, have been marked by a first peak during the spring, followed by significant reductions in COVID-19 cases in the summer months, and a second wave in the fall. In Latin America and Caribbean, COVID-19 epidemics in several countries peaked in the summer, corresponding to months with highest influenza activity in the region. Countries from regions with less pronounced influenza activity including South Asia and Sub-Saharan Africa, showed more heterogeneity in COVID-19 epidemics seen to date. However, similarities in COVID-19 and influenza trends were evident within select countries irrespective of region.
Conclusion Ecological consistency in COVID-19 trends seen to date with influenza trends suggest the potential for shared individual, structural, and environmental determinants of transmission. Using a descriptive epidemiological framework to assess shared regional trends for rapidly emerging respiratory pathogens with better-studied respiratory infections may provide further insights into the differential impacts of non-pharmacologic interventions and intersections with environmental conditions. Ultimately, forecasting trends and informing interventions for novel respiratory pathogens like COVID-19 should leverage epidemiologic patterns in the relative burden of past respiratory pathogens as prior information.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
No external funding was received for the work presented here.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
No IRB and/or ethics committee approvals were required for this work.
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Footnotes
Email Addresses of Authors Stefan Baral: sbaral{at}jhu.edu
Katherine Rucinski: rucinski{at}jhu.edu
Jean Olivier Twahirwa Rwema: jtwahir1{at}jhmi.edu
Amrita Rao: arao24{at}jhu.edu
Neia Prata Menezes: nprata{at}jhu.edu
Daouda Diouf: dioufda{at}endatiersmonde.org
Adeeba Kamarulzaman: adeeba{at}ummc.edu.my
Nancy Phaswana-Mafuya: refilwep{at}uj.ac.za
Sharmistha Mishra: sharmistha.mishra{at}utoronto.ca
The ranking system for this analysis was initially conceptualized as a way to investigate similarities in the burden of COVID-19 and influenza cases across countries and regions in the absence of more complete COVID-19 data. Given that nearly a full year of COVID-19 cases are now available, we have revised this approach to more directly compare seasonal dynamics for both influenza and flu using both cases and cases per capita. In doing so, we are able to comment on observed regional differences in seasonal trends for both COVID-19 and influenza using both measures.
Data Availability
All data reported in this manuscript are publicly available. Influenza data were abstracted from FluNet, a global web-based tool developed by the World Health Organization for influenza virological surveillance, which captures weekly laboratory confirmed influenza cases. COVID-19 data through 31 May, 2020 were abstracted from the World Health Organization Coronavirus Situation Report.
https://www.who.int/influenza/gisrs_laboratory/flunet/en/
https://reliefweb.int/report/world/coronavirus-disease-covid-19-situation-report-132-31-may-2020
